Sign In
Get Clay Free →

Suggestions

    Mike Atieh

    Board Member and Chair of the Audit Committee at Oyster Point Pharma

    Professional Background

    Michael G. Atieh is a distinguished finance executive with a comprehensive background in the pharmaceutical and biotechnology sectors. His career spans over three decades, during which he has held numerous influential roles, significantly impacting financial strategy and corporate governance in the life sciences industry.

    Most notably, Mr. Atieh served as the Executive Vice President, Chief Financial and Business Officer at Ophthotech Inc. (NASDAQ: OPHT) from September 2014 until his retirement in March 2016. In this role, he was instrumental in overseeing the company’s financial operations and strategic initiatives, aligning with Ophthotech’s mission to develop innovative treatments for ocular diseases.

    Before joining Ophthotech, Mr. Atieh held the position of Executive Chairman at Eyetech Inc., a prominent player in the biotechnology space, where he guided the company until its acquisition by Valeant Pharmaceuticals in 2012. His tenure at Eyetech was marked by his commitment to advancing biopharmaceutical innovations, which continued to develop under Valeant’s umbrella.

    From 2005 until 2009, he was the Executive Vice President and Chief Financial Officer of OSI Pharmaceuticals (NASDAQ: OSIP). Here, he successfully navigated the financial landscape of the company, leading critical initiatives that solidified OSI Pharmaceuticals' stature in the biotechnology community.

    Mr. Atieh’s extensive career includes a significant chapter with Merck and Co., Inc. (NYSE: MRK), where he dedicated over 20 years to the company in various senior executive roles. His positions at Merck included Vice President of U.S. Human Health, Senior Vice President of Merck Medco Managed Care, Vice President of Public Affairs, Vice President of Government Relations, and Treasurer. These roles allowed him to develop a deep understanding of both corporate finance and regulatory considerations in the healthcare industry.

    He began his professional journey at Arthur Young (now known as Ernst & Young), climbing the ranks to become an Audit Manager. His early career in public accounting provided a solid foundation for his future roles in corporate finance and management.

    Education and Achievements

    Mr. Atieh boasts a Bachelor of Arts (B.A.) in Accounting and Economics from Upsala College, which equipped him with the analytical skills and economic insights necessary for his successful finance career. His education laid the groundwork for a professional trajectory defined by strategic vision and financial acumen.

    In addition to his impressive educational background, Mr. Atieh has significantly contributed to corporate governance through his various board memberships. He currently serves on the Board of Directors of Chubb Limited (NYSE: CB), where he is an active member of the Risk and Finance Committee and previously chaired the Audit Committee for six years. His leadership role at Chubb further showcases his commitment to ensuring robust financial practices in the insurance sector.

    As Chairman of the Board at electroCore (NASDAQ: ECOR), Mr. Atieh continues to leverage his expertise in finanical oversight and strategic governance. At electroCore, he chairs the Audit Committee and contributes valuable insights to the Nom/Gov Committee, reinforcing the company's commitment to sound financial management.

    Moreover, Mr. Atieh is on the Board of Directors of Immatics N.V. (NASDAQ: IMTX) and serves as Chairman of the Audit Committee. His ongoing influence on the audit and financial committees of these organizations underscores his integral role in promoting transparency and accountability in the biotech sphere.

    In addition to his role at Immatics, Mr. Atieh also sits on the Board of Directors of Oyster Point Pharma (NASDAQ: OYST), where he holds the position of Chairman of the Audit Committee. His previous board experience includes Theravance Biopharma (NASDAQ: TBPH) from 2014 to 2015, where he was a member of the Audit Committee and contributed significantly to the financial strategies of the organization, as well as OSI Pharmaceuticals where he served as both a member of the Board and Chairman of the Audit Committee from 2003 to 2005. His prowess in financial oversight in both public and private sectors have established him as a trusted leader.

    Achievements

    Throughout his illustrious career, Mike Atieh has demonstrated exceptional leadership and a commitment to excellence. His strategic oversight has not only paved the way for financial growth within the organizations he has been part of, but has also placed him at the forefront of financial governance in the biotechnology and pharmaceutical industries. Mr. Atieh's influence extends beyond mere numbers; he aspires to foster environments of innovation and ethical standards in corporate practices.

    His journey, marked by significant executive roles and a keen understanding of public and private company dynamics, positions Mr. Atieh as a respected figure in the industry. His accomplishments and ongoing contributions to corporate boards reflect a lifelong dedication to advancing financial integrity and operational excellence in the biotechnology sector.

    From overseeing mergers and acquisitions to spearheading innovative financial practices, Mr. Atieh's track record exhibits a balanced blend of strategic agility and operational depth. As he continues to impact the industry through his board leadership roles, Mike Atieh remains a sought-after expert and a pivotal influence on the future of financial strategy in biotechnology and pharmaceuticals.

    Related Questions

    How did Mike Atieh's experience at Merck prepare him for his executive roles in the biotechnology sector?
    What key strategies did Mike Atieh implement during his tenure as Executive Vice President at Ophthotech?
    How has Mike Atieh contributed to corporate governance in his roles on various boards?
    What insights can be gained from Mike Atieh's approach to financial oversight in the life sciences industry?
    How has Mike Atieh's educational background in Accounting and Economics influenced his career trajectory?
    Mike Atieh
    Add to my network

    Location

    Port St Lucie, Florida, United States